ÂÜÀòÂÒÂ×

James A. Breckenridge is a seasoned executive with extensive experience in the healthcare and biopharmaceutical sectors. As the Chairman, Chief Executive Officer, and President of Pfanstiehl, Inc. since March 2013, Breckenridge leads a global provider of specialized products for biopharmaceutical applications, focusing on high-purity carbohydrates and amino acids. In addition, Breckenridge co-founded Med Opportunity Partners, LLC in 2007, a private equity firm dedicated to investing in healthcare companies, and served as Chairman of Reliable Biopharmaceutical Holdings, Inc. until December 2016. Prior to these roles, Breckenridge held positions at UBS Capital Americas, LLC and was an Associate at Kidder, Peabody & Company. Breckenridge holds an MBA in Finance from Columbia Business School and a BA in History from Colgate University.